The results of the clinical investigation showed that most of the patients in whom the missense variant in SCN1A was detected had migraine symptoms with typical aura, such as visual, sensory, motor, and speech symptoms, and dizzy attacks, in addition to headache and paralysis. Here, SCN1A is linked to migraine disorder.